Ключевые слова:
сахарный диабет 2-типа, мозговой нейротрофический фактор, IL-1β, хроническая ишемия мозга.Библиографические ссылки
Dedov II. et al. Algorithms for specialized medical care for patients with diabetes mellitus, ed. I.I. Dedova, M.V. Shestakova, A.Yu. Mayorova 9th issue. Diabetes. 2019;22(1S1):1-144. (In Russ)
Zakharov VV, Sleptsova KB, Martynova OO. Chronic cerebral ischemia: a view from the 21st century. RMJ. 2021;29(5):45-49.
Rachin AP, Vygovskaya SN, Nuvakhova MB, Doroginina AYu. Chronic cerebral ischemia - from correct diagnosis to adequate therapy. RMJ. 2015; 23(12): 694-698. (In Russ)
Samoilova YuG, Rotkank MA., Zhukova NG. et al Markers of cognitive impairment and glycemic variability in patients with diabetes mellitus. Journal Neurol. Psychiatrist. 2018; (4):48–51. (In Russ)
Solovyova EYu, Farrakhova KI, Karneev AN, Chipova DT. The role of phospholipids in ischemic brain damage. Journal of Neurology and Psychiatry. S.S. Korsakov. 2016;116(1):104-112. (In Russ)
Tanashyan MM., Antonova KV., Lagoda OV, et al. Resolved and unresolved issues of cerebrovascular pathology in diabetes mellitus. Annals of Clinical and Experimental Neurology. 2021;15(3):5-14. (In Russ)
Fedin AI. Diagnosis and treatment of chronic cerebral ischemia. Consilium Medicum. 2016;18(2):8-12. (In Russ)
Khybyrtova M R, Dolgova I N, Baturin VA, Karpov S M, Simkhes YuV. New pathogenetic aspects in chronic cerebral ischemia. Medical Bulletin of the North Caucasus. 2022;17(1):14-16. (In Russ)
Shadrichev FE, Shklyarov EB, Grigorieva NN. The use of anti-VEGF therapy in the treatment of diabetic macular edema. Ophthalmological statements. 2011;4(1):83-93. (In Russ)
Shulginova AA, Laskov VB, Bystrova NA, Karaulov AV. Immunological disorders in chronic cerebral ischemia. Immunology 2017; 2(38):108-112. (In Russ)
Bodhankar S, Chen Y, Lapato A, Vandenbark AA, Murphy SJ, Saugstad JA, et al. Regulatory CD8 (+) CD122 (+) T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells. Metab Brain Dis. 2015; 30: 911–24.
Charrad R, Berraïes A, Hamdi B, Ammar J, Hamzaoui K, Hamzaoui A. Anti-inflammatory activity of IL-37 in asthmatic children: Correlation with inflammatory cytokines TNF-α, IL-β, IL-6 and IL-17 A. Immunobiology. 2016; 221: 182–187.
Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28 costimulation: from mechanism to therapy. Immunity. 2016; 44: 973–88.
Eshimova, Sh., Ollanova, Sh., Khakimova, S., & Djurabekova, A. Assessment of motor disorders and the rate of disease progression in patients with essential tremor. Journal of Problems of Biology and Medicine, 2016; 2 (87): 147-150. (In Russ)
Takhirovna DA, Otabekovich SA, Axmatjonovich G A, & Mirxamzaevna M The Nature of Cognitive Impairment in Patients with Astheno-Neurotic Syndrome. nveo-natural volatiles & essential oils journal| nveo, M 2021; 5942-5948.
Amonova Z, Djurabekova A, & Khamedova F. Epilepsy against the background of hypothalamic-pituitary system dysfunction from the perspective of gender differences. Збірник наукових праць SCIENTIA. 2021;
Djurabekova AT, Vaseeva UK, Djurabekova ST, Amonova ZK. Adequate Assessment of Factors Leading to Speech Impairment in Young Children. 2021;15(1):167-70. Available from: https://conferencepublication.com/index.php/aoc/article/view/ 698
Takhirovna DA, Otabekovich SA, Axmatjonovich G A, & Mirxamzaevna M The Nature of Cognitive Impairment in Patients with Astheno-Neurotic Syndrome. nveo-natural volatiles & essential oils journal| nveo, M 2021; 5942-5948.
Jalalova DZ, Avazovan MM, & Vyazikova NF. Ophthalmological and Clinical and Biochemical Characteristics of Patients with Essential Arterial Hypertension. Eurasian Medical Research Periodical, 2022;13:180-182.
Kholmurodov D B, Djurabekova A, Isanova S, & Igamova S. Evaluation of treatment efficiency and informativity of mri studies in patients with migraine. Journal of Neurology and Neurosurgical Research. 2020;
Takhirovna JA, Vladimirovna SK, & Fedorovna VN. A comprehensive approach to the diagnosis of impaired walking in patients with dyscirculatory encephalopathy. World Bulletin of Public Health, 2023;19: 13-17.
Gaibiev A, Djurabekova A, & Niyozov Sh. Differential Diagnostic Criteria for Polyneuropathies. Trends And Perspectives for The Development of Science and Insight in The Minds of Globalization, 2017; 569. (In Russ)
Everett, B.M.; Donath, M.Y.; Pradhan, A.D.; Thuren, at al. Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes. J. Am. Coll. Cardiol. 2018; 71: 2392–2401.
Folco EJ, Mawson TL, Vromman A, Bernardes-Souza B, at al. Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production through Interleukin-1α and Cathepsin G. Arterioscler. Thromb. Vasc. Biol. 2018; 38: 1901–1912.
Perego C, Fumagalli S, Miteva K, Kallikourdis M, De Simoni MG. Combined Genetic Deletion of IL (Interleukin)-4, IL-5, IL-9, and IL-13 Does Not Affect Ischemic Brain Injury in Mice. Stroke. 2019; 50: 2207–15.
Shah PK. Inflammation, infection and atherosclerosis. Trends Cardiovasc. Med. 2019; 28: 468–472.
Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA at al. The role of inflammation in diabetes: Current concepts and future perspectives. Eur. Cardiol. 2019; 14: 50–59.
Van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020; 8: 325–36.
Wang X, Zhou Y, Tang D, Zhu Z, Li Y, Huang T, et al. ACC1 (Acetyl Coenzyme A Carboxylase 1) Is a Potential Immune Modulatory Target of Cerebral Ischemic Stroke. Stroke. 2019; 50: 1869–78.